Skip to main content
. 2022 Mar 21;13:794139. doi: 10.3389/fphar.2022.794139

TABLE 1.

Variations of R-6.

R-6 Formulation 1 Formulation 2 Formulation 3 Formulation 4 Formulation 5
Rehmanniae Radix (Di-huang) Rehmanniae Radix (Di-huang) Rehmanniae Radix (Di-huang) Rehmanniae Radix (Di-huang) Rehmanniae Radix (Di-huang) Rehmanniae Radix (Di-huang)
Dioscoreae Rhizoma (Shan-yao) Dioscoreae Rhizoma (Shan-yao) Dioscoreae Rhizoma (Shan-yao) Dioscoreae Rhizoma (Shan-yao) Dioscoreae Rhizoma (Shan-yao) Dioscoreae Rhizoma (Shan-yao)
Corni Fructus (Shan-zhu-yu) Corni Fructus (Shan-zhu-yu) Corni Fructus (Shan-zhu-yu) Corni Fructus (Shan-zhu-yu) Corni Fructus (Shan-zhu-yu) Corni Fructus (Shan-zhu-yu)
Moutan Cortex (Mu-dan-pi) Moutan Cortex (Mu-dan-pi) Moutan Cortex (Mu-dan-pi) Moutan Cortex (Mu-dan-pi) Moutan Cortex (Mu-dan-pi) Moutan Cortex (Mu-dan-pi)
Poria (Fu-ling) Poria (Fu-ling) Poria (Fu-ling) Poria (Fu-ling) Poria (Fu-ling) Poria (Fu-ling)
Alismatis Rhizoma (Ze-xie) Alismatis Rhizoma (Ze-xie) Alismatis Rhizoma (Ze-xie) Ginseng Radix et Rhizoma (Ren-shen) Alismatis Rhizoma (Ze-xie) Alismatis Rhizoma (Ze-xie)
Aucklandiae Radix (Mu-xiang) Chaenomelis Fructus (Mu-gua) Astragali Radix (Huang-qi) Ligustri Lucidi Fructus (Nv-zhen-zi) Cinnamomi Ramulus (Gui-zhi)
Amomi Fructus (Sha-ren) Aucklandiae Radix (Mu-xiang) Zingiberis Rhizoma Recens (Sheng-jiang) Eclipta prostrata (Mo-Han-Lian) Aconiti Lateralis Radix Praeparata (Fu-zi)
Citri Reticulatae Pericarpium (Chen pi) Arecae Semen (Bing-lang) Jujubae Fructus (Da-zao) Ligustri Lucidi Fructus (Nv-zhen-zi)
Ginseng Radix et Rhizoma (Ren-shen) Aconiti Lateralis Radix Praeparata (Fu-zi)
Pinelliae Rhizoma (Ban-xia) Zingiberis Rhizoma (Gan-jiang)
Atractylodis Macrocephalae Rhizoma (Bai-zhu) Glycyrrhizae Radix et Rhizoma (Gan-cao)
Glycyrrhizae Radix et Rhizoma (Gan-cao) Zingiberis Rhizoma Recens (Sheng-jiang)
Jujubae Fructus (Da-zao)
Tsaoko Fructus (Cao-guo)

Rehmannia-6 complex (R-6, Liu-wei-di-huang-wan) was the most used Chinese medicine formulation in the cohorts showing beneficial effect on diabetic kidney disease. Variations of R-6 were identified from a published existing clinical practice guideline developed from expert consensus and pilot clinical service program, which is undergoing a randomized clinical trial for evaluation.